focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
any news or rumours about the situation with their funding? last RNS in apr suggested that the discussions were ongoing with no certainty to the outcome!
now if I could predict that with any certainty....... like you i feel it may dip again this week, i didnt sell for a small profit either. i'm quite happy to hold this one for a bit. my guess is it wont breech 25 this week, seems to be a snagging point.
Strop and Adobong speak sense, do your own research (DYOR) is the most important thing followed by never put down more than you can afford to lose! I started with 1k then 1.5 and now deal between 2k and 5k on each share. its not much, but i can absorb a total loss if one company goes under. Never be afraid to pull out when you've made a decent profit, its hard to predict the top and dont be scared to make a loss as well, esp if the sh1t looks like hitting the fan. stop losses are a good way of covering this even though i dont use them. the final thing is try and get a balanced portfolio, buy AIM but try and have decent earning blue chips with good dividends as a back up. As for picking shares, read the boards, look at market sentiment and DYOR. And last but not least, Best of luck!
who said we were investing? all shares have an element of risk, this one has more than others, but if you look at the market there will always be shares that recover, e.g. Taylor Wimpey and others that go to the wall like Bradford and Bingley. it depends on your appetite for risk and if you think its totally dead or worth a speculative punt.
you really don't like this share do you?? i'm not wasting time, if this company is rescued/ bought out/ finds extra funding it has the potential to make money, if the drugs successfully pass the trials they are currently in. the problem for AZM is they dont have the cash to make it to the end of the trials. all ifs and maybes but i've made decent money trading on the highs and lows of this share.
interesting times ahead! hopefully good news, but not necessarily for the staff. The pharma i worked for got rid of the senior management and "suddenly" were in the process of being taken over within 6 months (and gave me my notice)! I would be surprised if no-one had a look, esp takeda.
fallen on his sword or gently pushed to allow a change of direction/sell off of assets?
obv had my sixth sense on again last week, and i still nearly bought in again. PB, i think i owe you a beer or 3.......... Good luck.
pipelines are always funny things to try and put a price on or even speculate whether they will come good. I've seen too many promising pharma pipelines disappear and leave a void. I'm still debating whether to buy in again because of the price, but i think i'd need to see some positive trials results and maybe a payment triggered from one before i'll hop back in. GL
PB is this good news or bad? how much money did they have left for this year and is it running out yet?
ta for the opinion, will probably hold for a bit and look at the divi as well.
shame about rift, a good share, unfortunately it never realised its full potential, though without the funding it never would and it was a good deal for IGS. I'm debating whether to bail on RAB, breached my 17% profit rule and i've got an itchy trigger finger. any thoughts?
I see RAB have a long position held on RIFT which are subject to a takeover. Rift board postings are inclined to believe there may be another bid in the pipeline. Whatever happens should realise some money for RAB as the deal is for 13p a share and the holding was bought at 12.25p.
what you expecting out of RAB by the year end? they seem to be recovering well and making some decent investments.
more good news for SKS. this venture to convert M&S surplus food waste should hopefully provide a good steady income, though I would love to see more details of the deal. hopefully bodes well for the share price after the rights issue.
have a look through the postings and also the news releases. then have a look at the financial data, thisismoney is a fairly decent site for this. prospects look good, mid to long term, esp given the areas this sompany is already in. short term, it could be volatile cos of the rights issue.
I have to admit i've not looked into any of the alternative energy companies. Whats the general situation with them, are they long term ventures or are they looking for govt support or jv's from bigger energy companies? I'm purely in NG for the divi and its defensive characteristics to counterbalance my higher risk holdings in the AIM.